About this trial
The goal of this clinical trial is to test the efficacy of Fathers for Change (F4C) compared to standard Batterer Intervention for fathers with a history of Intimate Partner Violence. The main question\[s\] it aims to answer are:
1. Is F4C more efficacious than standard BIP in reducing family violence and child mental health impairment? 2. What are the trajectories of therapeutic change targets across interventions? 3. Does father's emotion regulation and reflective functioning mediate the relationship between the two interventions and child-related outcomes? Participants will be randomized to either Fathers for Change on Batterer Intervention.
Eligibility criteria
Qualifiers
have at least one 6 month to 12-year-old biological child with whom they have contact;
had an incident of IPV within the last 12 months prior to screening with their child's mother (based on court/police records, coparent or self-report);
have a currently open or recently investigated (in the last 6 months) case with CT DCF
are able to complete assessments in English or Spanish;
Disqualifiers
an active full/no contact protective order pertaining to their child because this will preclude participation in the father-child play assessment (many men will have protective orders pertaining to their partners, but it is more common for men to still be allowed contact with their children);
physiological addiction to a substance that requires detoxification. Fathers will be evaluated using the Drug Abuse Screening Test and AUDIT. If fathers report significant difficulties with physiological withdrawal (e.g., alcohol tremors or dope sickness) they will be referred for detox services. They can be re-evaluated following a detox program with documentation from the detox center of successful completion and clean urine screen;
cognitive impairment that will not allow for understanding of the study interventions (a mini mental state score <25);
current untreated psychotic disorder;
Trial design
Treatments tested in this trial
- Fathers for Change
- Duluth BIP
Treatment groups
Sponsors and collaborators
Yale University
Lead sponsor
University of Connecticut
Collaborator
University of Delaware
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator